TH95071A - Compound aqueous suspension 4 - [[4 - [[4- (2-cyanoethenyl) -2,6-dimethylphenil] - amino] -2-pyrimidinyl] - amino ) - Benzonitrile - Google Patents
Compound aqueous suspension 4 - [[4 - [[4- (2-cyanoethenyl) -2,6-dimethylphenil] - amino] -2-pyrimidinyl] - amino ) - BenzonitrileInfo
- Publication number
- TH95071A TH95071A TH701003069A TH0701003069A TH95071A TH 95071 A TH95071 A TH 95071A TH 701003069 A TH701003069 A TH 701003069A TH 0701003069 A TH0701003069 A TH 0701003069A TH 95071 A TH95071 A TH 95071A
- Authority
- TH
- Thailand
- Prior art keywords
- amino
- dimethylphenil
- cyanoethenyl
- benzonitrile
- pyrimidinyl
- Prior art date
Links
- -1 2-cyanoethenyl Chemical group 0.000 title claims abstract 4
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzenecarbonitrile Natural products N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 title claims 4
- 150000001875 compounds Chemical class 0.000 title claims 2
- 239000007900 aqueous suspension Substances 0.000 title 1
- 239000011859 microparticle Substances 0.000 claims abstract 3
- 239000005426 pharmaceutical component Substances 0.000 claims abstract 3
- 230000001225 therapeutic effect Effects 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims 2
- YIBOMRUWOWDFLG-ONEGZZNKSA-N rilpivirine Chemical compound CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC=2C=CC(=CC=2)C#N)=N1 YIBOMRUWOWDFLG-ONEGZZNKSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 abstract 2
- 208000037357 HIV infectious disease Diseases 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 239000000470 constituent Substances 0.000 abstract 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 2
- 238000010255 intramuscular injection Methods 0.000 abstract 2
- 239000007927 intramuscular injection Substances 0.000 abstract 2
- 239000002105 nanoparticle Substances 0.000 abstract 2
- 239000002726 nonnucleoside reverse transcriptase inhibitor Substances 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 238000010254 subcutaneous injection Methods 0.000 abstract 2
- 239000007929 subcutaneous injection Substances 0.000 abstract 2
Abstract
DC60 (13/09/50) การประดิษฐ์นี้เกี่ยวข้องกับองค์ประกอบทางเภสัชกรรมสำหรับการใช้ผ่านการฉีดภายใน กล้ามเนื้อ หรือใต้ผิวหนัง ซึ่งประกอบรวมด้วยอนุภาคไมโคร-หรือนาโนของสารประกอบ NNRTI TMC278, ได้รับการแขวนลอยในพาหะแอเควียสที่ยอมรับได้ทางเภสัชกรรม, และการใช้ องค์ประกอบทางเภสัชกรรมดังกล่าวในการบำบัดรักษา และการป้องกันของการติดเชื้อ HIV การประดิษฐ์นี้เกี่ยวข้องกับองค์ประกอบทางเภสัชกรรมสำหรับการใช้ผ่านการฉีดภายใน กล้ามเนื้อ หรือใต้ผิวหนัง ซึ่งประกอบรวมด้วยอนุภาคไมโคร-หรือนาโนของสารประกอบ NNRTI TMC278, ได้รับการแขวนลอยในพาหะแอเควียสที่ยอมรับได้ทางเภสัชกรรม, และการใช้ องค์ประกอบทางเภสัชกรรมดังกล่าวในการบำบัดรักษา และการป้องกันของการติดเชื้อ HIV สิทธิบัตรยา DC60 (13/09/50) This invention relates to a pharmaceutical component for use through intramuscular or subcutaneous injection. These include micro- or nanoparticles of the NNRTI TMC278 compound, were suspended in a chemically acceptable ACID carrier, and the therapeutic use of such pharmaceutical constituents. And prevention of HIV infection. The invention involves a pharmaceutical component for use through intramuscular or subcutaneous injection. These include micro- or nanoparticles of the NNRTI TMC278 compound, were suspended in a chemically acceptable ACID carrier, and the therapeutic use of such pharmaceutical constituents. And prevention of HIV infection, drug patents
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH95071A true TH95071A (en) | 2009-04-09 |
| TH95071B TH95071B (en) | 2009-04-09 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA97641C2 (en) | AQUEOUS SUSPENSION 4 - $ 4 - $ 4- (2-CYANOETHENYL) -2,6-DIMETHYLPHENYL] AMINO] -2-PYRIMIDINYL] AMINO] BENZONITRILE (TMC278) ) -2,6-DIMETHYLPHENYL] AMINO] -2-PYRIMIDINYL] AMINO] BENZONITRILE (TMC278) | |
| EP4696380A3 (en) | Benzoxazepin oxazolidinone compounds and methods of use | |
| EA201101709A1 (en) | POLYCYCLIC ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | |
| MX2017003102A (en) | Liquid inhalation formulation comprising rpl554. | |
| WO2015184256A3 (en) | Biodegradable lipids for delivery of nucleic acids | |
| EA201492292A1 (en) | PREPARATION ANTIBODIES | |
| BR112015011036A2 (en) | heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections | |
| GEP201706780B (en) | Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c | |
| BR112014015568A2 (en) | phenyl carbamate compounds for use in the prevention or treatment of epilepsy | |
| TN2014000345A1 (en) | Pharmaceutical preparation containing an antivirally active dihydroquinazoline derivative | |
| EP3255043A3 (en) | N-(6-((2r,3s)-3,4-dihydroxybutan-2-yloxy)-2-(4-fluorobenzylthio)pyrimidin-4-yl)-3- methylazetidine-1-sulfonamide as chemokine receptor modulator | |
| MA32841B1 (en) | Compounds of cyclondica dipseibeptides and their use as drugs | |
| BR112014009242A8 (en) | pharmaceutical nanosuspension | |
| PH12014502407A1 (en) | New alfentanil composition for the treatment of acute pain | |
| TH95071A (en) | Compound aqueous suspension 4 - [[4 - [[4- (2-cyanoethenyl) -2,6-dimethylphenil] - amino] -2-pyrimidinyl] - amino ) - Benzonitrile | |
| TH95071B (en) | Compound aqueous suspension 4 - [[4 - [[4- (2-cyanoethenyl) -2,6-dimethylphenil] - amino] -2-pyrimidinyl] - amino ) - Benzonitrile | |
| TH132221A (en) | Pharmaceutical preparations for dermal use | |
| TH154771A (en) | New compound as Modulators of protein kinase (Novel compound as modulators of protein kinase) | |
| TH174318A (en) | Formula | |
| PL396319A1 (en) | Pharmaceutical formulation for the treatment of herpes simplex virus infection and application of the formulation | |
| TH1701007409A (en) | Benzoxepin oxasolidinone compounds and methods of use | |
| TH124352A (en) | Benzophyranil derivatives | |
| TH166182A (en) | "Pharmaceutical mixtures for the prevention or treatment of skin rashes" | |
| TH146553A (en) | Active pharmaceutical substances in crystal form. | |
| TH126114A (en) | PIPERAZINES AS ANTIMALARIAL AGENTS |